Summary
Summary This paper will first positthe This paper will first positthe rationale for intervention before onset, rationale for intervention before onset, then outline the current usual practice of then outline the current usual practice of treating schizophrenia and the treating schizophrenia and the determinants of that practice.Recent determinants of that practice.Recent developments that permit or demand a developments that permit or demand a change in this practice will then be change in this practice will then be elaborated.The article concludes with an elaborated.The article concludes with an elaboration of the currently known risks elaboration of the currently known risks and benefits of early intervention and benefits of early intervention research.The ethics of early intervention research.The ethics of early intervention are undergoinga paradigm shift, a shiftthat are undergoinga paradigm shift, a shiftthat supports early intervention research as supports early intervention research as being necessary to bring empirical balance being necessary to bring empirical balance to territory that is currently to territory that is currently overpopulated with zealous opinions. overpopulated with zealous opinions.
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EARLY INTERVENTION EARLY INTERVENTION
The specific rational for early intervention The specific rational for early intervention research comes from the fact that although research comes from the fact that although current treatments control positive current treatments control positive symptoms, they do not affect the unknown symptoms, they do not affect the unknown neurobiological processes that create lifeneurobiological processes that create lifelong, usually irreversible deficits in mental long, usually irreversible deficits in mental and emotional capacity. These processes and emotional capacity. These processes appear to be most active usually between appear to be most active usually between 1 and 3 years prior to and following onset 1 and 3 years prior to and following onset of disorder. Because of this, special attenof disorder. Because of this, special attention and concentrated study, including tion and concentrated study, including treatment trials, should target this period. treatment trials, should target this period.
Early intervention was not a serious Early intervention was not a serious consideration until the mid 1990s. Before consideration until the mid 1990s. Before this, it was considered clinically and ethithis, it was considered clinically and ethically correct not to use antipsychotic cally correct not to use antipsychotic pharmacotherapy until a diagnosis of pharmacotherapy until a diagnosis of psychosis could be made. The standard psychosis could be made. The standard practice with prodromal symptoms was to practice with prodromal symptoms was to wait until psychosis was clearly present bewait until psychosis was clearly present before applying psychosis-specific treatments. fore applying psychosis-specific treatments. Diagnosis and treatment of schizophrenia Diagnosis and treatment of schizophrenia was delayed for four reasons. First, antiwas delayed for four reasons. First, antipsychotic medications were known to psychotic medications were known to control positive symptoms of schizophrenia control positive symptoms of schizophrenia and to prevent or delay relapse, but no one and to prevent or delay relapse, but no one thought they might also alter its natural thought they might also alter its natural history, much less prevent or delay the dishistory, much less prevent or delay the disorder itself. Second, neuroleptics had sideorder itself. Second, neuroleptics had sideeffects that could be unpleasant, disabling effects that could be unpleasant, disabling and even irreversibly damaging. There was and even irreversibly damaging. There was little reason to expose patients to such risks little reason to expose patients to such risks unless their use was demonstrably necesunless their use was demonstrably necessary. Third, the so-called prodromal signs sary. Third, the so-called prodromal signs of schizophrenia were quite nonof schizophrenia were quite non-specific, specific, making prediction too inexact to be useful making prediction too inexact to be useful for pre-emptive intervention. As such, idenfor pre-emptive intervention. As such, identified 'at-risk' groups invariably tified 'at-risk' groups invariably contained contained high proportions of 'falsehigh proportions of 'false-positive propositive prodromals'; i.e. persons whose 'prodromal' dromals'; i.e. persons whose 'prodromal' symptoms turned out to precede or to symptoms turned out to precede or to portend some disorder other than psychoportend some disorder other than psychosis. Poor predictability exposed far too sis. Poor predictability exposed far too many of such individuals to unnecessary many of such individuals to unnecessary risks. Fourth, the diagnosis of schizorisks. Fourth, the diagnosis of schizophrenia was delayed until it could no longer phrenia was delayed until it could no longer be denied in order to be denied in order to avoid the stigma avoid the stigma associated with the label. 
RECENT DEVELOPMENTS RECENT DEVELOPMENTS
The 1990s saw new data and developments The 1990s saw new data and developments that impacted on each of the above reasons that impacted on each of the above reasons supporting delayed intervention in schizosupporting delayed intervention in schizophrenia. First, evidence emerged suggesting phrenia. First, evidence emerged suggesting that existing treatments for psychosis might that existing treatments for psychosis might also affect the natural history of the disalso affect the natural history of the disorder. This included numerous studies of order. This included numerous studies of first-episode schizophrenia demonstrating first-episode schizophrenia demonstrating a correlation between a shorter duration a correlation between a shorter duration of untreated psychosis (DUP) and better of untreated psychosis (DUP) and better prognosis. These data have been reviewed prognosis. These data have been reviewed extensively and will not be detailed here extensively and will not be detailed here (McGlashan, 1996 (McGlashan, 1996a a, 1999 , 2000 . The evi-, 1999 The evi-, , 2000 . The evidence is positive but equivocal insofar as dence is positive but equivocal insofar as several studies have not replicated this several studies have not replicated this correlation. Furthermore, even if this corcorrelation. Furthermore, even if this correlation between earlier intervention and relation between earlier intervention and better course proves to be solid, a causal better course proves to be solid, a causal relationship has yet to be demonstrated relationship has yet to be demonstrated (McGlashan, 1999) . To do so with the (McGlashan, 1999) . To do so with the greatest scientific credibility would require greatest scientific credibility would require randomising a group of patients with firstrandomising a group of patients with firstepisode psychosis to delayed treatment, episode psychosis to delayed treatment, which would be unethical. An ethical effort which would be unethical. An ethical effort is underway to test for causality using a is underway to test for causality using a quasi-experimental design (McGlashan, quasi-experimental design (McGlashan, 1996 1996b Johannessen ; Johannessen et al et al, 2001) . Until a , 2001). Until a causal direction can be delineated, the altercausal direction can be delineated, the alternate hypothesis cannot be dismissed that nate hypothesis cannot be dismissed that the DUP effect is a byproduct of innate the DUP effect is a byproduct of innate (premorbid) prognosis, i.e. patients who (premorbid) prognosis, i.e. patients who are destined to be among the most ill also are destined to be among the most ill also present at onset in ways that result in a long present at onset in ways that result in a long DUP (McGlashan, 1999) . DUP (McGlashan, 1999) .
The evidence that early treatment may The evidence that early treatment may affect the natural history of the psychosis affect the natural history of the psychosis also comes from two studies of treatment also comes from two studies of treatment prior to onset. In a pioneering investigation, prior to onset. In a pioneering investigation, Falloon (1992) applied home-based stress Falloon (1992) applied home-based stress management to prodromally symptomatic, management to prodromally symptomatic, high-risk individuals identified by primary high-risk individuals identified by primary care practitioners in a small county in Britcare practitioners in a small county in Britain. The intervention may have prevented ain. The intervention may have prevented psychosis and reduced the incidence of psychosis and reduced the incidence of schizophrenia, but the results are limited schizophrenia, but the results are limited in their significance because of the small in their significance because of the small sample size. The second study by McGorry sample size. The second study by McGorry et al et al (2002) involved randomising opera-(2002) involved randomising operationally defined prodromally symptomatic tionally defined prodromally symptomatic patients at high risk to open label treatpatients at high risk to open label treatments, one being an atypical neuroleptic ments, one being an atypical neuroleptic plus enriched psychosocial intervention, plus enriched psychosocial intervention, and the other being standard supportive and the other being standard supportive psychosocial intervention without neuropsychosocial intervention without neuroleptics. The results are significant and supleptics. The results are significant and support the hypothesis that prodromal phase port the hypothesis that prodromal phase intervention can delay or prevent the onset intervention can delay or prevent the onset of psychosis. of psychosis.
The second development in the 1990s The second development in the 1990s leading to a paradigm shift in the ethics leading to a paradigm shift in the ethics of early intervention was the introduction of early intervention was the introduction of novel neuroleptics, such as clozapine, of novel neuroleptics, such as clozapine, risperidone and olanzapine. These agents risperidone and olanzapine. These agents proved to have equal efficacy to tra proved to have equal efficacy to traditional ditional neuroleptics and had fewer sideneuroleptics and had fewer side-effects. effects. Particularly auspicious has been the relative Particularly auspicious has been the relative scarcity of extrapyramidal side-effects: scarcity of extrapyramidal side-effects: akathisia, neuroleptic malignant syndrome akathisia, neuroleptic malignant syndrome and tardive dyskinesia (Beasley and tardive dyskinesia (Beasley et al et al, , 1996 (Beasley et al et al, , , 1999 Glazer, 2000 Glazer, 1996 Glazer, , 1999 Glazer, 2000a a, ,b 
, 1997a a, ,b b). These agents have their own ). These agents have their own set of undesirable side-effects, such as set of undesirable side-effects, such as s113 s113 weight gain and somnolence, and we do not weight gain and somnolence, and we do not yet know about their long-term safety. yet know about their long-term safety. Nevertheless, the benefit:risk ratio of the Nevertheless, the benefit:risk ratio of the 'novel' medications is currently superior to 'novel' medications is currently superior to the standard neuroleptics, which impacts, the standard neuroleptics, which impacts, in turn, on the benefit:risk ratio of early inin turn, on the benefit:risk ratio of early intervention. tervention. Perhaps the most important developPerhaps the most important development in the 1990s altering the conservative ment in the 1990s altering the conservative status quo about early intervention was the status quo about early intervention was the demonstration by McGorry demonstration by McGorry et al et al that subthat subgroups of patients with 'prodromal' sympgroups of patients with 'prodromal' symptoms could be identified who possessed a toms could be identified who possessed a very high risk of 'converting' to psychosis very high risk of 'converting' to psychosis in the near future, i.e. within the ensuing in the near future, i.e. within the ensuing year. The criteria included clinical, funcyear. The criteria included clinical, functional and demographic phenomenologies tional and demographic phenomenologies that were easy to identify and operationathat were easy to identify and operationalise. The Australian team found that lise. The Australian team found that between 20 and 41% of patients so between 20 and 41% of patients so defined became psychotic within 1 year defined became psychotic within 1 year (Yung (Yung et al et al, 1996 (Yung et al et al, , 1998 McGorry, , 1996 McGorry, , , 1998 McGorry, 1998) . 1998).
B R I T I S H J O UR N A L O F P SYC HI AT RY B R I T I S H J O UR N A L O F P S YC H I AT RY
The Australian criteria were incorpoThe Australian criteria were incorporated by the author and colleagues into a rated by the author and colleagues into a Scale of Prodromal Symptoms (SOPS) and Scale of Prodromal Symptoms (SOPS) and a Structured Interview of Prodromal a Structured Interview of Prodromal Symptoms (SIPS) (Miller Symptoms (SIPS) (Miller et al et al, 1999) . This , 1999). This scale has identified prodromal persons for scale has identified prodromal persons for a study of early intervention in the a study of early intervention in the Prevention through Risk Identification, Prevention through Risk Identification, Management, and Education (PRIME) Management, and Education (PRIME) prodromal clinic in the US. In individuals prodromal clinic in the US. In individuals identified as prodromal by the SIPS, the identified as prodromal by the SIPS, the rate of conversion to psychosis has been rate of conversion to psychosis has been comparable to that of the Australian popucomparable to that of the Australian populations (Miller lations (Miller et al et al, 2003 (Miller et al et al, ), thus validating , 2003 , thus validating the high predictability of these criteria in the high predictability of these criteria in another sample from another research another sample from another research centre in another country. centre in another country.
Such high predictability is new to the Such high predictability is new to the field of pre-onset markers of vulnerability field of pre-onset markers of vulnerability and needs replication. Nevertheless, the and needs replication. Nevertheless, the results thus far are significant enough to results thus far are significant enough to call into question the ethics of the conservacall into question the ethics of the conservative 'wait and see' practice, i.e. the status tive 'wait and see' practice, i.e. the status quo. Such behaviour on the part of quo. Such behaviour on the part of clinicians may be protecting 60% of a clinicians may be protecting 60% of a prodromal sample (the false-positives) from prodromal sample (the false-positives) from unnecessary treatment, but it may also be unnecessary treatment, but it may also be keeping 40% of the sample (the true posikeeping 40% of the sample (the true positives) from the knowledge of a risk that is tives) from the knowledge of a risk that is real and potentially treatable. The treatreal and potentially treatable. The treatability of psychosis in the prodromal phase ability of psychosis in the prodromal phase is largely unknown but is being tested in is largely unknown but is being tested in ongoing clinical trials. Should treatment ongoing clinical trials. Should treatment prove to be effective in delaying or preprove to be effective in delaying or preventing the onset of psychosis, then a 'wait venting the onset of psychosis, then a 'wait and see' attitude could be regarded as and see' attitude could be regarded as unprotective, if not unethical. unprotective, if not unethical.
A further argument against early identi-A further argument against early identification is exposure to the stigma of being fication is exposure to the stigma of being labelled as at risk for psychosis. This risk labelled as at risk for psychosis. This risk is especially onerous to false-positive prois especially onerous to false-positive prodromal patients who receive no benefit dromal patients who receive no benefit from the label in the form of appropriate from the label in the form of appropriate treatments to offset the risk. But what is treatments to offset the risk. But what is the risk of stigma? No one has yet the risk of stigma? No one has yet attempted to define stigma or to measure attempted to define stigma or to measure its negative impact. For example, we are its negative impact. For example, we are not aware of any research suggesting that not aware of any research suggesting that being in a psychiatric clinic stigmatises being in a psychiatric clinic stigmatises anyone. It is vital to clarify that the populaanyone. It is vital to clarify that the populations being studied in the Australian and tions being studied in the Australian and North American prodromal clinics are North American prodromal clinics are actively symptomatic and treatmentactively symptomatic and treatmentseeking. Study 'individuals' are mental seeking. Study 'individuals' are mental health consumers or patients, not asymptohealth consumers or patients, not asymptomatic citizens (even if at high risk). They matic citizens (even if at high risk). They come to the study recognising that somecome to the study recognising that something is wrong or not 'quite right'. They thing is wrong or not 'quite right'. They come already accepting the role of patient, come already accepting the role of patient, if not the label. if not the label.
RISKS AND BENEFITS RISKS AND BENEFITS OF EARLY INTERVENTION OF EARLY INTERVENTION
What are the risks and benefits of pre-onset What are the risks and benefits of pre-onset detection and intervention research as illudetection and intervention research as illustrated by the PRIME clinic protocol in strated by the PRIME clinic protocol in the context of contemporary psychiatric the context of contemporary psychiatric practice in America? practice in America?
Risk revolves primarily around two Risk revolves primarily around two issues: drug side-effects and stigma. Conissues: drug side-effects and stigma. Concerning drug side-effects cerning drug side-effects, the immediate , the immediate side-effects associated with atypical neuroside-effects associated with atypical neuroleptics are modest in frequency and very leptics are modest in frequency and very modest in serious adverse effects modest in serious adverse effects. Long-. Longterm side-effects are not yet known. Curterm side-effects are not yet known. Currently, benefits rently, benefits are substantial and known are substantial and known risks in the absence of weight gain are risks in the absence of weight gain are modest. modest.
The potential risk of stigmatising partiThe potential risk of stigmatising participants as psychotic and doomed to chronic cipants as psychotic and doomed to chronic illness is certainly present and should be illness is certainly present and should be recognised. In practice, however, we have recognised. In practice, however, we have found that this risk can be managed with found that this risk can be managed with a judicious balance of education about a judicious balance of education about psychosis and counselling about probability psychosis and counselling about probability and the uncertainty of prediction. We do and the uncertainty of prediction. We do not continually confront or challenge a not continually confront or challenge a patient who denies our assessment and patient who denies our assessment and judgement about risk for psychosis, but judgement about risk for psychosis, but we also do not collude with their 'not we also do not collude with their 'not knowing'. Although it may be tempting to knowing'. Although it may be tempting to keep information of risk from a person to keep information of risk from a person to avoid distress, such 'protection' can also avoid distress, such 'protection' can also be seen as violating that person's civil be seen as violating that person's civil liberties and right to know. Preliminary liberties and right to know. Preliminary results suggest the criteria indicating immiresults suggest the criteria indicating imminent risk have a sensitivity of 40%, meannent risk have a sensitivity of 40%, meaning the level of predictability is no longer ing the level of predictability is no longer negligible. We feel a person who meets negligible. We feel a person who meets these criteria has a right to know the risks. these criteria has a right to know the risks. Such persons certainly have a right to deny Such persons certainly have a right to deny the reality of risk, but we have no right to the reality of risk, but we have no right to deny it for them. deny it for them.
The main benefit of participating in The main benefit of participating in such research lies mainly in learning one's such research lies mainly in learning one's actual risk for psychosis or other mental actual risk for psychosis or other mental illnesses over time. For patients who are true positives, particiFor patients who are true positives, participation will clarify this as well, with the pation will clarify this as well, with the additional benefit that such patients additional benefit that such patients will receive active treatment sooner than will receive active treatment sooner than is usually the case for first-episode is usually the case for first-episode psychosis.
psychosis.
An 'indirect' benefit of treatment An 'indirect' benefit of treatment research in the prodromal phase of psychoresearch in the prodromal phase of psychosis is that research participants are more sis is that research participants are more likely to possess intact capacities to provide likely to possess intact capacities to provide informed consent. Compromised compeinformed consent. Compromised competency in schizophrenia research or treattency in schizophrenia research or treatment usually accompanies the later stages ment usually accompanies the later stages of the disorder. of the disorder.
To conclude, the data informing the To conclude, the data informing the benefit:risk ratio are insufficient to justify benefit:risk ratio are insufficient to justify prodromal intervention as standard pracprodromal intervention as standard practice at the present time, but the data are tice at the present time, but the data are sufficient to justify prodromal intervention sufficient to justify prodromal intervention research. In short, we need to stop research. In short, we need to stop shadow-boxing with our own projections shadow-boxing with our own projections of doom and illuminate our current gloom of doom and illuminate our current gloom of ignorance with high-quality scientific of ignorance with high-quality scientific investigation. investigation. 
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